Russell Franklin counsels private and publicly held companies in connection with complex strategic transactions, including structuring and negotiating mergers and acquisitions (M&A), minority investments, and joint venture transactions for strategic and financial clients. His practice also includes general stock and asset transactions, and purchases and sales resulting from bankruptcy and out-of-court restructurings. Russell routinely partners with life sciences transactions (LST) lawyers on life sciences M&A and matters that include one or more equity components. Russell is a member of the firm’s SPAC Task Force and has counseled clients contemplating SPAC and de-SPAC transactions.